Side effets of atituberculosis drugs;Les effets indesirables des antituberculeux

Tunisie Medicale

Volumn 76, Issue 2, 1998, Pages 1041-1046

  Drira, Ikram ^a   Jrad, Samia ^a   Ben Arif, Jouda ^a   Souissi, Raoudha ^a   Daghfous, Riadh ^b   Bellkahia, Chelbi ^b   Chebbi, Mohamed Lakhdar ^b  

^a ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Antituberculosis drugs; Side effects

Indexed keywords

ETHAMBUTOL; ISONIAZID PLUS RIFAMPICIN; PYRIDOXINE; RIFATER; STREPTOMYCIN;

ACNE; ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSENSITIVITY; INNER EAR DISEASE; MAJOR CLINICAL STUDY; NEUROLOGICAL COMPLICATION; OTOTOXICITY; RASH; SKIN DISEASE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; DRUG HYPERSENSITIVITY; EAR DISEASES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; JOINT DISEASES; LIVER DISEASES; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; SKIN DISEASES; TIME FACTORS; VISION DISORDERS;

EID: 7344254109     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. BEER FJ. Intolélonces et allergies médicamenteuses. Médecine et hygiène 1981, 39; 1286-1289
2. CRHAULET P., BOULAHBAL F. Essai clinique d'une combinaison en proportions fixes de frais médicaments dans le traitement de la tuberculose. Tuberde and lung disease 1995, 76: 407 - 412
3. DUROUX P. Surveillance et accidents de la chimiothérapie anti-tuberculeuse. Rev Prat 1979; 29: 2681 - 2690
4. DAUTZENBERG B., DEKIMECHE A. Chimiothérapie antituberculeuse - Editions techniques. - Encycl. Med. Chir. (Paris-France), Pneumologie, 6-019 - A 35, 1995, 10p.
5. DRIRA L., SOUISSI R, DAKHLAOUI R., JEGUIRIM M.S., CHEBBI M.L. Désensibilisation orale aux antituberculeux Rev, Pneumol Clin 1997, 53. 104 -106
6. BOUSSABAH E. Les effets indésirables des antituberculeux: Application d'une méthode d'imputabilité utilisée dans les centres de pharmacovigilance: A propos de 70 cas. Thèse Méd Sfax 1992
7. BELLABAS, KHALED S., AIT KHALED N., BOULAHBAL F, CHAULET P. Essai thérapeutique d'une combinaison d'lsoniazide, de Rifampicine et de Pyrazinamide au oours des deux premiers mois de traitement de la tuberculose pulmonaire. Rev Fr Mal Respir 1989; 6 59 - 64.
8. GOBLE M., ISEMAN MD., MADSEN LA., WAITE D., ACICERSON L, HORSBURGH R. Treament of 171 patients with pulmonary tuberculosis resistant to Isoniazid and Rifompin. N Engl J Med 1993; 328: 527 - 532;
9. GROSSET J. Les données expérimentales actuelles sur la chimiothèrapie de courte durée. Bulletin de l'UICT 1978; 53: 281 - 283.
10. HONG KONG TUBERCULOSIS SERVICES. Adverses reactions to short course regimens containing Streptomycin. Tuberde 1976; 57: 81.
11. LEOPHONTE P., DIDIER A., CARRE PH, POUCHELON E., ROUQUET R.R Modalités thérapeutiques de la tuberculose pulmonaire Rev Ptat 1990; 40: 719-724.
12. Recommandations de la Société de Pneumologie de langue fiançaise. taitement de la tuberculose en France. Revue Fr Mal Resp 1984; 1-59-62.
13. COHEN LK., GEORGE W., SMITH R. Isoniazid - Induced - acne and Pellagra Arch dermatol 1974; 109: 377-381
14. . SOYEZ P., SURPAS P., VESTRI R, PHILIP - JOET F, ARNAUD A. Réaction inhabituelle au Pirilène Rev Fr. Allergol. 1988; 1: 21
15. COOMBS D.L, OBRIV RJ, GIE-IEK LJ USPHS tuberculose short course chemotherapy bial 21 : Effectiveness, toxicity snd acceptability. The report of final results. Ann intern Med 1990; 1 12: 397 - 406.
16. DUTT AK, MOERS D., STGAD W. Short-course chemotherapy for tuberculosis with mainly twice weekly Isoniazid and Rifomprn Am.J.med 1984,77.233-241
17. SHEUER PJ, SUMMERFELD LS, SHES LOCK S. Rifampin hepatitis. A clinical ond histological study. Lancet 1974; I- 491 - 425
18. MOLNA C, LESOBER, MORELEC R, STAIN JP. Hepatic toxicit. Rev. Fr. Mal Resp. (suppl 1); 29: 2681 - 2690
19. PRETET S., PERDRIZET S. La toxicité du Pyrazinamide dans les traitements anti-tuberculeux. Rev Fr mol Resp 1980, 8 307 - 320
20. BERNSTEIN RALPH E. Isoniazid Hepatotoxicity and acetylation during tuberculosis chemoprophylaxis Am Rev Resp Dis 1980; 121 : 429 - 430
21. HUGUES FC., MOORE N., JULEN D. Les interactions observées avec les médicaments antituberculeux - Rev. Pneumol. Clin 1988; 44; 278 - 285
22. FRIEDMAN LN, SULLIVAN GM, BEVILAGUA RP, LOSCOS R. Tuberciosis screening in alcoholics and drug addicts. Am. Rev. Respir Dis 1987; 136: 1188- 1192.
23. SUMAR TOJO E. When tuberculosis fails. A social bihavioral of patient treatment Am.Rev.Respir.Dis 1993; 147: 1311 - 1320
24. LAGUENY A. Neuropathies sensitives. Rev Prat 1992, 42 38 - 42
25. SISKIND MS, THIENNEMANN D, KIRLIN L. Tsoniazid - induced neurotoxicity in chronic dialysis Report of three cases and a review of the litterature. Nephron 1993; 64 - 303 - 306.
26. SNIDER DE. Pyridoxine supplementation during Isoniazid therapy, tubercle 1980; 61: 191-196.
27. ELLARD GA, HALLARD RM. Observations of the reduction of renal elimination of urate in man caused by the administration of Pyrazinamide. Tubercle 1976, 57: 97 - 103.
28. BARNES PF, BARROWS SA. Tuberculosis in the 1990s . Ann. intern. med. 1993; 119: 400 - 410
29. GONZALEZ J, DAUTZENBERG B. Incidents et accidents du traitement antituberculeux. La revue du praticien Médecine générale 1996: 343 11 - 15
30. CHENG - HUEI EFF, CHING - JYH LEE. Thrombocytopenia a rare but potentially serious side effect of initially and interruped use of Rifampicin. Chest 1989, 96 202 - 203